XML 46 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1

REVENUE (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation by revenue source

The following table presents the Company’s revenues disaggregated by revenue source:

						Year Ended December 31,
(In thousands)						2023						2022						2021
Screening
Medicare Parts B & C						$	701,400					$	545,458					$	438,646
Commercial						992,244						743,238						569,944
Other						171,057						136,007						53,718
Total Screening						1,864,701						1,424,703						1,062,308
Precision Oncology
Medicare Parts B & C						$	188,689					$	197,327					$	197,394
Commercial						181,318						177,518						180,177
International						153,277						117,738						109,913
Other						105,826						108,905						74,192
Total Precision Oncology						629,110						601,488						561,676
COVID-19 Testing						$	5,955					$	58,088					$	143,103
Total						$	2,499,766					$	2,084,279					$	1,767,087

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration